Fixed-Price or Firm-Fixed-Price? Contractor’s Right to Seek Reimbursement of Legal Costs in Defending Qui Tam Suits
Client Alert | 1 min read | 11.20.18
On October 26, 2018, the Court of Federal Claims denied the government’s motion to dismiss a contractor’s lawsuit seeking reimbursement of legal costs incurred in defense of a False Claims Act qui tam suit, and found that the contractor sufficiently pled the requirements for allowability. Tolliver Group, Inc. v. United States, 2018 WL 5307076 (Fed. Cl. Oct. 26, 2018). Tolliver alleged that the legal costs are allocable to the initial fixed-price, level of effort contract, while the government argued that a modification changed the contract to firm-fixed-price—precluding any cost adjustments absent a contract clause providing otherwise. The Court found that the qui tam suit could only have been brought based on Tolliver’s work under the initial task order, and held that the terms and conditions under the initial contract remained in full force and effect, including—by operation of law under the Christian doctrine—the provisions of FAR § 31.205-47 covering allowable legal costs.
Contacts
Insights
Client Alert | 4 min read | 04.08.26
Cosmetics Under the Microscope: FDA’s Expanding Regulatory Reach Under MoCRA
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) marked the most significant expansion of FDA’s authority over cosmetics in 80 years — and the agency is putting that authority to work. From the launch of a new adverse event reporting tool to forthcoming rules on fragrance allergens and good manufacturing practices (GMP), FDA is reshaping the regulatory landscape for manufacturers, packers, and distributors of cosmetic and personal care products.
Client Alert | 11 min read | 04.08.26
Client Alert | 3 min read | 04.07.26
Answering the Top Seven Questions About Pending Section 301 Deadlines


